Financials
Cash Data
- Monthly Burn
- Burn Trend
- Dilution Risk
- SEC Filing
Key Stats
Upcoming Catalysts
FDA decisions, readouts and PDUFA dates · scored by probability of approval
| Catalyst | Drug / Treatment | Stage | Prob. of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|
NVST Catalyst Timeline
Dated clinical, regulatory and corporate events for Envista Holdings Corporation
Past FDA Catalysts and PDUFA Decisions
How NVST actually traded into and out of each decision
| Date | Drug | Catalyst | Stage | Reaction | Event Move % | Best Trade % |
|---|---|---|---|---|---|---|
| No matching catalysts | ||||||
Drug Pipeline Intelligence
| Drug | Indication | Phase | PTRS | rNPV | Status | Enroll | Velocity | Design | Est. Completion | ML Signal | Last Change |
|---|
Clinical Trial Results
Readouts, endpoints and source filings for every NVST program
| Drug Name | Indication | Phase | Date | Trial Results Summary | Title | Source |
|---|
Inside Trades
| Insider | Side | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Reis MischaOfficer (SVP, Strategy & Bus. Dev.) | Sell | -8,000 27,321 held | $27.50 | 08/20/2026 |
Hedge Fund 13F Activity
Hedge Funds invested in NVST
| Fund | % of Portfolio | Current MV | Shares Owned | Activity |
|---|---|---|---|---|
| PARKMAN HEALTHCARE PARTNERS LLC | 0.6 % (-60 %) | 6.60 M | 281.00 K | -49.27% ( -272.91 K) |
Ownership Trends
NVST Short Interest
Shares sold short, counted twice a month.
Options Data
Option Volume
Option Chain Statistics
| Expiry | Call Vol | Put Vol | Vol P/C | Call OI | Put OI | OI P/C | IV Call | IV Call OI-Wtd | IV Call Vol-Wtd | IV Put | IV Put OI-Wtd | IV Put Vol-Wtd |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-20 | ||||||||||||
Real-Time Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last | Vol | OI | Last | Vol | OI | |
| No data available | ||||||
Calls vs Puts by Expiry
Competitive positioning
How NVST ranks across every disease it competes in
NVST News
Envista Announces Pricing of $430 Million of Senior Notes
Envista Holdings Corporation announced the pricing of $430 million in Senior Notes due 2033. The offering, priced at 99.482% of the principal amount, is set to close around November 24, 2026. The proceeds will be used to repay a term loan and for general corporate purposes. J.P. Morgan, BofA, and Wells Fargo are the active bookrunners.
Read more →Envista Reports Third Quarter 2026 Results
Envista Holdings Corporation reported third quarter results for 2026, achieving sales of $691 million with a core sales growth of 2.7% compared to the previous year. The company also reported a GAAP diluted EPS of $3.11 and adjusted EBITDA of $106 million. CEO Paul Keel expressed confidence in raising the full-year earnings guidance due to strong momentum.
Read more →Envista Announces Release of 2025 Sustainability Report
Envista Holdings released its 2025 Sustainability Report, detailing progress in waste reduction and community support. The company cut waste generation by 40% and water consumption by 19% year-over-year. Additionally, the Envista Smile Project donated $2.4 million to serve nearly 20,000 patients. The firm also reported a 17% decrease in lost time injury rates during the period.
Read more →Envista Schedules Third Quarter 2026 Earnings Call
Envista Holdings Corporation will announce its third quarter 2026 financial results on November 4, 2026. The results will be discussed during a conference call at 2:00 PM PT, which will be available via webcast. A replay of the call will be accessible for one year. Envista is recognized as a leader in the dental industry with a strong brand portfolio.
Read more →Envista Announces Participation in Baird 2026 Global Healthcare Conference
Envista Holdings Corporation announced its participation in the Baird 2026 Global Healthcare Conference, scheduled for September 15, 2026. The event will include a fireside chat from 9:40 to 10:10 AM ET. A live audio webcast will be available on Envista's investor relations website, allowing broader access to stakeholders.
Read more →Envista Reports Second Quarter 2026 Results
Envista Holdings Corporation reported a strong second quarter for 2026, with sales reaching $731 million and a core sales growth of 5% compared to the previous year. The company also saw a significant increase in adjusted diluted EPS, which rose by 58%. CEO Paul Keel highlighted the positive momentum and operational excellence contributing to margin expansion, prompting an upward revision of the full-year outlook for sales growth and adjusted EBITDA.
Read more →Envista to Host Investor Day on September 17, 2026
Envista Holdings Corporation has announced an Investor Day scheduled for September 17, 2026. The event will feature a management presentation followed by a Q&A session, allowing investors to engage directly with company leaders. It will be webcast live, with a replay available later. In-person attendance requires prior registration.
Read more →Envista Schedules Second Quarter 2026 Earnings Call
Envista Holdings Corporation will announce its second quarter 2026 financial results on August 5, 2026. The discussion will take place during a conference call starting at 2:00 PM PT, which will be accessible via the company's website. A replay of the call will be available for one year, ensuring ongoing access to the information.
Read more →Envista Reports First Quarter 2026 Results
Envista Holdings Corporation reported strong first quarter results for 2026, achieving a 9.5% core revenue growth and a 50% increase in adjusted EPS compared to the previous year. The company also announced a $300 million share repurchase program, reflecting confidence in its financial performance. However, it faced challenges with negative operating and free cash flows during the quarter.
Read more →Envista Schedules First Quarter 2026 Earnings Call
Envista Holdings Corporation will announce its financial results for the first quarter of 2026 on May 6, 2026. The company will host a conference call at 2:00 PM PT to discuss these results, which will be accessible via a webcast. A replay of the call will be available for one year, and relevant materials will be posted on their website.
Read more →Envista Reports Fourth Quarter 2025 Results
Envista Holdings Corporation reported strong financial results for Q4 2025, achieving a 10.8% core revenue growth and a 22% increase in adjusted EBITDA. The company also noted a full-year revenue growth of 6.5% and a significant return of $166 million to shareholders through share repurchases. CEO Paul Keel emphasized the positive performance across all major business segments and regions.
Read more →Envista Schedules Fourth Quarter 2025 Earnings Call
Envista Holdings Corporation will announce its fourth quarter 2025 financial results on February 5, 2026. The results will be discussed during a conference call starting at 2:00 PM PT. Investors can access the call via phone or through a webcast on the company's website.
Read more →Envista to Present at the 44th Annual J.P. Morgan Healthcare Conference
Envista Holdings Corporation will present at the 44th Annual J.P. Morgan Healthcare Conference on January 12, 2026. The presentation is scheduled from 3:45 to 4:25 pm PST and will be available via a live audio webcast. A replay will be accessible for 30 days on the company's website.
Read more →Envista Announces Participation in 8th Annual Evercore Healthcare Conference
Envista Holdings Corporation will participate in the 8th Annual Evercore Healthcare Conference on December 3, 2025. The event will feature a fireside chat from 12:30 to 1:15 pm ET. A live audio webcast will be accessible on the company's investor relations website.
Read more →Envista Announces Release of 2024 Sustainability Report
Envista Holdings Corporation released its 2024 Sustainability Report, detailing its commitment to sustainable practices. Key highlights include a $1.9 million donation to enhance oral care access and a 13% reduction in safety incidents. CEO Paul Keel emphasized the company's dedication to creating lasting value for stakeholders.
Read more →Envista Reports Third Quarter 2025 Results
Envista Holdings Corporation reported strong Q3 2025 results with $670 million in sales, marking a 9.4% increase from the previous year. Adjusted EPS rose 167% to $0.32, while adjusted EBITDA also saw a significant increase of 77%. Despite a GAAP net loss of $30 million, the company achieved profitability in its Spark aligners business.
Read more →Envista Schedules Third Quarter 2025 Earnings Call
Envista Holdings Corporation will announce its third quarter 2025 financial results on October 30, 2025. A conference call will follow at 2:00 PM PT, lasting about one hour. The call will be available via webcast, and a replay will be accessible for one year. Additional materials will be posted on their website.
Read more →Envista Reports Second Quarter 2025 Results
Envista Holdings Corporation reported strong financial results for Q2 2025, with sales reaching $682 million and a core sales growth of 5.6% year-over-year. The company also saw a significant increase in adjusted EBITDA and EPS, prompting an upward revision of its full-year guidance. CEO Paul Keel noted accelerated growth across all business segments.
Read more →Envista Schedules Second Quarter 2025 Earnings Call
Envista Holdings Corporation will announce its second quarter 2025 financial results on July 31, 2025. The earnings call will start at 2:00 PM PT and last about one hour. Investors can access the call via phone or through a webcast on the company's website. A replay will be available after the call.
Read more →Envista Announces Participation in Stifel 2025 Jaws & Paws Conference
Envista Holdings Corporation announced its participation in the Stifel 2025 Jaws & Paws Conference. The fireside chat is scheduled for May 28, 2025, from 1:50 to 2:20 pm ET. A live audio webcast will be available on the company's investor relations website.
Read more →